Incyte Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (41)

View All

Latest Posts

About This Stock More About This Stock
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Article By: StockNews
Monday, June 14, 2021 12:31 AM EDT
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
In this article: AZN, INCY, AMGN Also: SPY, CNCR
Read
Incyte Q2 Earnings And Revenues Beat Estimates
Article By: Zacks Investment Research
Tuesday, August 4, 2020 9:55 AM EDT
Incyte came out with quarterly earnings of $1.24 per share.
In this article: INCY
Read
4 Biotech Stocks That Could Keep Beating Wall Street
Article By: Zacks Investment Research
Monday, November 11, 2019 1:41 PM EDT
The size of the biotechnology market was valued at $399.4 billion in 2017 and is expected to witness a compound annual growth rate of 9.9% during the forecast period 2018-2024. Here are four stock choises.
In this article: ACAD, INCY, CHRS, BIIB Also: BMY, LLY, ADPT, CELG, TAK, ALEC, NGM
Read
5 Drug/Biotech Stocks Likely To Surpass On Earnings In Q3
Article By: Zacks Investment Research
Thursday, October 24, 2019 1:40 PM EDT
The third-quarter earnings season for the pharma/biotech sector started last week, putting up an impressive performance so far in the reporting cycle.
In this article: GSK, INCY, JAZZ, VRTX, ZTS
Read
16 Stocks With The Highest Long-Term Sales Growth Rate
Article By: Benzinga
Wednesday, October 23, 2019 4:20 PM EDT
Longtime investors know the stock market is forward-looking. Here are the 16 S&P 500 stocks with the biggest revenue growth over the past five years.
In this article: AGN, CNC, CRM, LEN, ABMD, INCY, AVGO, CHTR, NKTR, FB, TWTR, FANG, ANET, KHC Also: UBER, AMZN, NFLX, TSLA
Read
All Posts

Latest Tweets for $INCY

No tweets yet!